Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?
Publication
, Report
Abernethy, AP; Allen LaPointe, N; Wheeler, JL; Irvine, RJ; Patwardhan, M; Matchar, D
August 28, 2009
Duke Scholars
Publication Date
August 28, 2009
Citation
APA
Chicago
ICMJE
MLA
NLM
Abernethy, A. P., Allen LaPointe, N., Wheeler, J. L., Irvine, R. J., Patwardhan, M., & Matchar, D. (2009). Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?
Abernethy, A. P., Nancy Allen LaPointe, J. L. Wheeler, R. J. Irvine, M. Patwardhan, and D. Matchar. “Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base?,” August 28, 2009.
Abernethy AP, Allen LaPointe N, Wheeler JL, Irvine RJ, Patwardhan M, Matchar D. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 2009 Aug.
Abernethy, A. P., et al. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 28 Aug. 2009.
Abernethy AP, Allen LaPointe N, Wheeler JL, Irvine RJ, Patwardhan M, Matchar D. Horizon Scan: To What Extent Do Changes in Third-Party Payment Affect Clinical Trials and the Evidence Base? 2009 Aug.
Publication Date
August 28, 2009